Prana Investor Presentation and Audio Recording
FEBRUARY 2014: MELBOURNE, Australia and NEW YORK, USA: Prana Biotechnology (ASX:PBT / NASDAQ:PRAN) this morning delviered a presentation for investors regarding the results of its Phase 2 clinical trial of PBT2 in patients with Huntington’s disease.
The full presentation, including audio, can be viewed here.
The slide deck can be viewed here.
Source: Prana Biotechnology Limited